These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 22203471
21. Role of the TGFβ/PDCD4/AP-1 Signaling Pathway in Nasopharyngeal Carcinoma and Its Relationship to Prognosis. Ma J, Xuan SH, Li Y, Zhang ZP, Li XH. Cell Physiol Biochem; 2017; 43(4):1392-1401. PubMed ID: 29017171 [Abstract] [Full Text] [Related]
22. The clinical significance of PYCR1 expression in renal cell carcinoma. Weijin F, Zhibin X, Shengfeng Z, Xiaoli Y, Qijian D, Jiayi L, Qiumei L, Yilong C, Hua M, Deyun L, Jiwen C. Medicine (Baltimore); 2019 Jul; 98(28):e16384. PubMed ID: 31305441 [Abstract] [Full Text] [Related]
24. An essential role of PDCD4 in progression and malignant proliferation of gastrointestinal stromal tumors. Ding L, Zhang X, Zhao M, Qu Z, Huang S, Dong M, Gao F. Med Oncol; 2012 Sep; 29(3):1758-64. PubMed ID: 21850542 [Abstract] [Full Text] [Related]
25. Prognostic role of PPAR-γ and PTEN in the renal cell carcinoma. Zhu C, Wei J, Tian X, Li Y, Li X. Int J Clin Exp Pathol; 2015 Sep; 8(10):12668-77. PubMed ID: 26722456 [Abstract] [Full Text] [Related]
29. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma. Petraki CD, Gregorakis AK, Vaslamatzis MM, Papanastasiou PA, Yousef GM, Levesque MA, Diamandis EP. Tumour Biol; 2006 Jan; 27(1):1-7. PubMed ID: 16340244 [Abstract] [Full Text] [Related]
30. Prognostic value of PD-1 and PD-L1 expression in patients with metastatic clear cell renal cell carcinoma. Ueda K, Suekane S, Kurose H, Chikui K, Nakiri M, Nishihara K, Matsuo M, Kawahara A, Yano H, Igawa T. Urol Oncol; 2018 Nov; 36(11):499.e9-499.e16. PubMed ID: 30131293 [Abstract] [Full Text] [Related]
31. High Novel Oncogene with Kinase-Domain (NOK) Gene Expression is Associated with the Progression of Renal Cell Carcinoma. Cao Q, Chen M, Li Z, Huang W, Jin Y, Ye X, Tong M. Clin Lab; 2016 Nov; 62(1-2):179-86. PubMed ID: 27012048 [Abstract] [Full Text] [Related]
32. High expression of Twist is associated with tumor aggressiveness and poor prognosis in patients with renal cell carcinoma. Ohba K, Miyata Y, Matsuo T, Asai A, Mitsunari K, Shida Y, Kanda S, Sakai H. Int J Clin Exp Pathol; 2014 Nov; 7(6):3158-65. PubMed ID: 25031735 [Abstract] [Full Text] [Related]
33. GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma. Xue Y, Wu G, Liao Y, Xiao G, Ma X, Zou X, Zhang G, Xiao R, Wang X, Liu Q, Long D, Yang J, Xu H, Liu F, Liu M, Xie K, Huang R. Br J Cancer; 2014 Apr 29; 110(9):2250-60. PubMed ID: 24595000 [Abstract] [Full Text] [Related]
37. Intratumoral expression of programmed death ligand 1 (PD-L1) in patients with clear cell renal cell carcinoma (ccRCC). Abbas M, Steffens S, Bellut M, Eggers H, Großhennig A, Becker JU, Wegener G, Schrader AJ, Grünwald V, Ivanyi P. Med Oncol; 2016 Jul 29; 33(7):80. PubMed ID: 27317388 [Abstract] [Full Text] [Related]
38. Protein phosphatase-2A is down-regulated in patients within clear cell renal cell carcinoma. Li J, Sheng C, Li W, Zheng JH. Int J Clin Exp Pathol; 2014 Jul 29; 7(3):1147-53. PubMed ID: 24696731 [Abstract] [Full Text] [Related]
39. ZFX is a Strong Predictor of Poor Prognosis in Renal Cell Carcinoma. Li C, Li H, Zhang T, Li J, Ma F, Li M, Sui Z, Chang J. Med Sci Monit; 2015 Nov 05; 21():3380-5. PubMed ID: 26540164 [Abstract] [Full Text] [Related]
40. Prognostic significance of miR-21 and PDCD4 in patients with stage II esophageal carcinoma after surgical resection. Zhang J, Ma L, Shi D, Zhang Z, Yao C, Zhao X, Xu Q, Wen P, He L. J Cell Biochem; 2018 Jun 05; 119(6):4783-4791. PubMed ID: 29331036 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]